Press Release
Lantheus Announces FDA Grants PDUFA Date for LNTH-2501 (Ga 68 edotreotide), a PET Diagnostic Imaging Kit Targeting Somatostatin Receptor-Positive (SSTR+) Neuroendocrine Tumors (NETs)
October 30, 2025
Read More at Our Investor Site
Because we make progress every day
Browse our latest press releases below, or visit our investor site directly for a complete list of all recent and archived press releases.
Press Release
Lantheus Announces FDA Acceptance of New Drug Application for MK-6240, a PET Imaging Agent Targeting Tau in Alzheimer’s Disease
October 28, 2025
Read More at Our Investor SitePress Release
Lantheus to Host Third Quarter 2025 Earnings Conference Call and Webcast on November 6, 2025, at 8:00 a.m. Eastern Time
October 23, 2025
Read More at Our Investor SitePress Release
Lantheus and GE HealthCare Announce Exclusive Licensing Agreement for Prostate Cancer Imaging Agent PYLARIFY® (Piflufolastat F 18) in Japan
September 24, 2025
Read More at Our Investor SitePress Release
Lantheus to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference
September 2, 2025
Read More at Our Investor SitePress Release
Lantheus Reports Second Quarter 2025 Financial Results and Provides Business Update
August 6, 2025
Read More at Our Investor SiteFor access to press releases before 2022 and full-text search capabilities, please visit our investor site.